NTBL (Notable Labs Ltd) Cumulative Company Assets

Notable Labs, Ltd. creates personalized oncology therapies through alliances with medical centers, utilizing the PPMP system to analyze drug efficacy. AI technical support and the conduct of trials have been outsourced to external contractors. This price chart available on the page shows that total assets amount to 0.00. The company is currently in the early stages of development, which entails an active cash burn.

Notable Labs Ltd (NTBL) Aggregate Company Assets: for the period 02/21/2024 - 11/02/2024

Financial and market metric breakdowns for Notable Labs Inc. (NTBL)

- share price and consensus valuation forecast:
Price Chart notablelabs.com|NTBL - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Notable Labs Corp|NTBL - Enterprise Value
- company book value details:
Book Value per Share Notable Labs|NTBL - Company Book Value|Capitalization to Book Value Ratio notablelabs.com|NTBL - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Notable Labs, Ltd.|NTBL - Long-Term Debt to Capital|Current Liabilities to Capital Notable Labs Corp|NTBL - Company Debts|Debt to Net Assets Ratio Notable Labs Corp|NTBL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Notable Labs|Quick Liquidity Indicator notablelabs.com
- earnings and market multiples details:
NTBL - Net Income
Basic company analysis:notablelabs.com (NTBL)

Total assets define the aggregate tangible and intangible base of an enterprise, allowing for an assessment of the resource scale available for business scaling. By analyzing the structure of total balance sheet assets, an investor can observe capitalization dynamics calculated inversely through return on assets (ROA). For Notable Labs, Ltd. (NTBL), this metric reflects the volume of investment in the high-tech functional diagnostics platform required for the personalization of oncological therapy.

Key competitors

ONC (beigene.com) - Aggregate Company Assets|HALO (Halozyme) - Company Total Assets|Cumulative Company Assets Revolution Medicines Inc (RVMD)|Company Total Assets AAPG|Company Total Assets CG Oncology Therapeutics (CGON)|Aggregate Company Assets UroGen Pharma Ltd. URGN|BCAX: Total Business Assets|Personalis - Company Total Assets|Erasca Inc (ERAS) - Cumulative Company Assets|DCTH: Company Total Assets|Company Assets Y-mAbs Corp (YMAB)|Aggregate Company Assets Aura Biosciences, Inc.|CADL: Aggregate Asset Value|Cumulative Company Assets ARAY (Accuray)|SLS (sellaslifesciences.com) - Aggregate Asset Value|Company Total Assets ACTU (Actuate Therapeutics, Inc)|CTOR - Cumulative Company Assets|HURA: Cumulative Company Assets|TARA - Company Total Assets|Fate Therapeutics (FATE) - Aggregate Company Assets|Aadi Bioscience - Aggregate Asset Value|TCRX (TScan Therapeutics Inc) - Company Total Assets|Company Assets Champions Oncology Corp CSBR|Aggregate Company Assets XBiotech Inc. (XBIT)|cel-sci.com - Total Business Assets|Aggregate Company Assets OS Therapies OSTX|radiopharmtheranostics.com (RADX) - Company Assets|ARTV: Cumulative Company Assets|Adlai Nortye Ltd. - Aggregate Business Assets|VERU: Company Total Assets|tempesttx.com (TPST) - Company Total Assets|XLO (Xilio Therapeutics Inc) - Company Total Assets|Aggregate Company Assets RENB|Aggregate Company Assets Mural Oncology plc (MURA)|Aggregate Company Assets KAPA (kairospharma.com)|Company Total Assets OKUR (OnKure Therapeutics)|CytoMed Therapeutics Ltd (GDTC) - Company Assets|CRIS: Cumulative Company Assets|Aggregate Asset Value APLM (Apollomics, Inc.)|Tharimmune Corp (THAR) - Aggregate Company Assets|ADVB (Advanced Biomed) - Aggregate Company Assets|GNPX (Genprex, Inc.) - Company Total Assets|Company Total Assets Calidi Bio|Company Total Assets SBFM|Aggregate Company Assets XBIO (xeneticbio.com)|Aggregate Company Assets Salarius SLRX|Company Total Asset Base Kitov Pharma (PPBT)|AONC: Cumulative Company Assets|Aggregate Asset Value BGNE (beigene.com)|Checkpoint Therapeutics, Inc. (CKPT) - Aggregate Company Assets|ELEV (elevationoncology.com) - Aggregate Company Assets|Cumulative Company Assets ICAD|IKNA (Ikena) - Aggregate Business Assets|Company Total Assets VIRX|morphosys.com - Total Business Assets|NAYA Biosciences Inc. - Cumulative Company Assets|Company Total Asset Base Ascentage Pharma Group International (AAPGV)